CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a large decline in short interest in May. As of May 29th, there was short interest totaling 293,249 shares, a decline of 88.5% from the May 14th total of 2,549,897 shares. Based on an average daily volume of 39,007,375 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX remained flat at $0.00 during trading on Thursday. 25,014 shares of the company’s stock traded hands, compared to its average volume of 33,760,633. CNBX Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.